CXCL2 and hepatocellular carcinoma: We also found the low-expressed CXCL2 exhibited potential prognostic significance in patients with HCC, and low expression of CXCL2 was associated with malignancy clinical features, such as AFP > 400 ng/ml, nodal metastasis, and higher grades.